The impact of accelerometer and heart rate data on hypoglycemia mitigation in type 1 diabetes

Journal of Diabetes Science and Technology

Volumn 8, Issue 1, 2014, Pages 64-69

  Stenerson, Matthew ^a   Cameron, Fraser ^b   Wilson, Darrell M ^a   Harris, Breanne ^a   Payne, Shelby ^a   Bequette, B Wayne ^b   Buckingham, Bruce A ^a  

^a STANFORD UNIVERSITY   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Accelerometer; Exercise; Hypoglycemia; Predictive low glucose suspend; Pump suspension; Type 1 diabetes

Indexed keywords

ACCELEROMETER; ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER SIMULATION; CONTINUOUS GLUCOSE MONITOR; FEMALE; HEART RATE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; MONITOR; PREDICTIVE LOW GLUCOSE SUSPEND ALGORITHM;

EID: 84900527301     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296813516208     Document Type: Article

References (31)

1. American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care. 2004;27(suppl 1):S58-S62.
2. Sonnenberg GE, Kemmer FW, Berger M. Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia. Diabetologia. 1990;33(11):696-703.
3. Diabetes Research in Children Network (DirecNet) Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care. 2006;29:20-25.
4. MacDonald MJ. Post-exercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care. 1987;10(5):584-588.
5. Tuominen JA, Karonen SL, Melamies L, Bolli G, Koivisto VA. Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia. 1995;38(1):106-111.
6. Guelfi KJ, Jones TW, Fournier PA. New insights into managing the risk of hypoglycaemia associated with intermittent high intensity exercise in individuals with type-1 diabetes mellitus. Sports Med. 2007;37:937-946.
7. Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care. 2001;24(4):625-630.
8. Bernardini AL, Vanelli M, Chiari G, et al. Adherence to physical activity in young people with type 1 diabetes. Acta Biomed. 2004;75(3):153-157.
9. Devadoss M, Kennedy L, Herbold N. Endurance athletes and type 1 diabetes. Diabetes Educ. 2011;37(2):193-207.
10. Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care. 2006;29(10):2200-2204.
11. Buckingham B, Cobry E, Clinton P, et al. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009;11(2):93-97.
12. Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system. Diabetes Technol Ther. 2009;11:207-210.
13. Buckingham B, Chase HP, Dassau E, et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care. 2010;33(5):1013-1017.
14. Cameron F, Wilson DM, Buckingham BA, et al. Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Technol. 2012;6(5):1142-1147.
15. Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14(3):205-209.
16. Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther. 2013;15(8):622-627.
17. Zephyr Technology Corporation. BioHarness™ 3 Data Sheet. Available from: http://www.zephyranywhere.com/media/pdf/BH-DS-P-BioHarness3-Data-Sheet- 20120919-V02.pdf.
18. Jovanov E, Milosevic M, Milenkovic A. A mobile system for assessment of physiological response to posture transitions. Conf Proc IEEE Eng Med Biol Soc. 2013;2013;7205-7208.
19. Kim JH, Roberge R, Powell JB, Shafer AB, Jon Williams W. Measurement accuracy of heart rate and respiratory rate during graded exercise and sustained exercise in the heat using the Zephyr BioHarness. Int J Sports Med. 2013;34(6):497-501.
20. Bangstad HJ, Danne T, Deeb LC, et al. ISPAD clinical practice consensus guidelines 2006-7. Insulin treatment. Pediatr Diabetes. 2007;8(2):88-102
21. Frohnhauer M, Woodworth J, Anderson J. Graphical human insulin time-activity profiles using standardized definitions. Diabetes Technol Ther. 2001;3(3):419-429.
22. Swan K, Steffen A, Dziura J, et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2009;32(2):240-244.
23. Plasqui G, Westerterp KR. Physical activity assessment with accelerometers: an evaluation against doubly labeled water. Obesity. 2007;15:2371-2379.
24. Gradmark A, Pomeroy J, Renström F, et al. Physical activity, sedentary behaviors, and estimated insulin sensitivity and secretion in pregnant and non-pregnant women. BMC Pregnancy Childbirth. 2011;11:44.
25. Balkau B, Mhamdi M, Oppert JM, et al. Physical activity and insulin sensitivity. Diabetes. 2008;57:2613-2618.
26. Ekelund U, Griffin SJ, Wareham NJ. Physical activity and metabolic risk in individuals with a family history of type 2 diabetes. Diabetes Care. 2007;30:337-342.
27. Simmons RK, Griffin SJ, Steele R, Wareham NJ, Ekelund U, the ProActive Research Team. Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial. Diabetologia. 2008;51:787-794.
28. Healy GN, Wijndaele K, Dunstan DW, et al. Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care. 2008;31:369-371.
29. Arvidsson D, Fitch M, Hudes ML, Tudor-Locke C, Fleming SE. Accelerometer response to physical activity intensity in normal-weight versus overweight African American children. J Phys Act Health. 2011;8(5):682-692.
30. Livingstone MB, Prentice AM, Coward WA, et al. Simultaneous measurement of free-living energy expenditure by the doubly labeled water method and heart-rate monitoring. Am J Clin Nutr. 1990;52(1):59-65.
31. Luke A, Maki KC, Barkey N, Cooper R, McGee D. Simultaneous monitoring of heart rate and motion to assess energy expenditure. Med Sci Sports Exerc. 1997;29(1):144-148.